Related Experiment Video
Updated: Jun 14, 2026
07:08
Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats
Published on: January 10, 2019
9.9K
SMOX Inhibition Preserved Visual Acuity, Contrast Sensitivity, and Retinal Function and Reduced Neuro-Glial Injury in
Moaddey Alfarhan1,2,3,4, Fang Liu1,2,3, Bayan R Matani1,2,3
1Program in Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia, Augusta, GA 30907, USA.
Cells
|January 8, 2025
Summary
Inhibiting spermine oxidase (SMOX) with MDL 72527 improved vision and reduced retinal damage in diabetic mice over 24 weeks. This suggests SMOX inhibition is a promising strategy for preserving sight in diabetic retinopathy.
Area of Science:
- Ophthalmology
- Neuroscience
- Metabolic Disorders
Background:
- Diabetic retinopathy causes significant vision loss due to retinal neurovascular changes.
- Effective treatments to preserve vision in diabetic patients are lacking.
- Spermine oxidase (SMOX) regulates polyamine metabolism and is implicated in neurodegeneration.
Purpose of the Study:
- To investigate the long-term effectiveness of SMOX inhibition on vision impairment and neuro-glial injury in a diabetic mouse model.
- To evaluate the impact of MDL 72527, a SMOX inhibitor, after 24 weeks of diabetes.
Main Methods:
- Utilized a streptozotocin-induced diabetic mouse model.
- Administered MDL 72527, a SMOX inhibitor, for 24 weeks.
- Assessed visual acuity, contrast sensitivity, inner retinal function, and neuro-glial markers (Tuj-1, synaptophysin, glutamine synthetase, vimentin).
Main Results:
- MDL 72527 treatment improved visual acuity, contrast sensitivity, and inner retinal function in diabetic mice.
- SMOX inhibition attenuated diabetes-induced changes in neuronal and glial markers.
- Neuro-glial markers Tuj-1, synaptophysin, glutamine synthetase, and vimentin showed improvement.
Conclusions:
- Long-term SMOX inhibition effectively preserves vision and mitigates neuro-glial damage in diabetic mice.
- Targeting SMOX signaling presents a potential therapeutic strategy for diabetic retinopathy.
- This approach may reduce retinal neuronal damage and preserve vision in diabetic patients.
